Direct answer on OEM and ODM scope
OEM is the appropriate route when a buyer selects an existing or near-existing device platform and needs controlled branding, color, packaging or limited configuration work. ODM is appropriate when the brief requires deeper industrial design, mechanism changes, new interfaces, tooling or an original platform. HYTANBIO begins both routes with a requirements and responsibility review. The team identifies the legal manufacturer, target market, primary container, dose logic, forecast, evidence expectations and ownership of design inputs. That review prevents “custom logo” from concealing functional changes and prevents a visual concept from being mistaken for an engineering release. The final route may be standard supply, semi-custom OEM, full-custom OEM or ODM depending on the technical delta and business case.
Eight-step development workflow
Each step has a decision, owner and output. Timing is quoted after input readiness is confirmed.
Requirements review
User needs, market, container, dose, forecast and responsibilities.
DFM assessment
Platform fit, interface risks, materials, process and test implications.
Proposal and quote
Scope, assumptions, deliverables, commercial terms and timing.
Design and tooling
Approved industrial design, drawings, molds and controlled changes.
Prototype build
Samples produced for defined engineering evaluation purposes.
Verification planning
Agreed tests, acceptance criteria, evidence and issue closure.
Pilot production
Process trial, inspection records, packaging and traceability review.
Production transfer
Released specification, approved sample, controls and delivery plan.
Customizable dimensions and boundaries
Customization may cover housing geometry, approved materials, color and finish, dose display, control layout, logo application, packaging, instructions language and accessory combinations. Changes to the container interface, drive system, needle path, spring profile, electronics, firmware or dose mechanism require deeper engineering and verification review than cosmetic changes. HYTANBIO records each request in a design-input and change-control process so affected drawings, risks, tests, tooling and documents can be identified. The customer must provide legitimate rights to all brands, artwork and protected design inputs. A rendered image or appearance sample confirms visual direction only; it does not authorize functional production. Final production follows the released design records, approved sample and signed specification.
Documentation and market responsibility
The project documentation matrix can include requirements, specifications, controlled drawings, material declarations, supplier records, inspection criteria, agreed test reports, packaging records and batch traceability. The exact set depends on device classification, target jurisdiction, party roles and contract. Company certificates, if supplied, must be checked for entity, site, scope, issuing body and validity. A certificate logo alone is not sufficient evidence that the final device is registered, cleared or approved. HYTANBIO supports the evidence plan and export coordination defined in the project; the regulatory responsibility of each party is confirmed in writing before development or supply proceeds.
Frequently asked procurement questions
OEM generally adapts an existing platform; ODM involves deeper original design, mechanism, interface or tooling work.
Potentially, after artwork rights, platform suitability, process capability, labeling and market responsibilities are reviewed.
Tooling ownership, maintenance, permitted use and end-of-life treatment are defined in the project contract.
Prototype quantity and purpose depend on the development plan and are stated in the quotation.
Not automatically. Roles, evidence and destination-market submissions are defined separately for each program.